Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Building Bridges Between ACC and Women's Cardiovascular Health Around the World.

Moraes G, Kovacs RJ.

J Am Coll Cardiol. 2019 Aug 27;74(8):1156-1158. doi: 10.1016/j.jacc.2019.07.033. No abstract available.

PMID:
31439223
2.

WITHDRAWN: Cardio-Oncology: Stronger Together.

Kovacs RJ, Burris HA 3rd.

J Am Coll Cardiol. 2019 Jul 31. pii: S0735-1097(19)36086-3. doi: 10.1016/j.jacc.2019.07.041. [Epub ahead of print]

PMID:
31404608
3.

2019 Methodology for Heart House Roundtables: A Report of the American College of Cardiology Solution Set Oversight Committee.

Morris PB, Kovacs RJ, Allen LA, Binder LG, Birtcher KK, Covington AM, Gluckman TJ, Williams KA Sr.

J Am Coll Cardiol. 2019 Aug 27;74(8):1116-1137. doi: 10.1016/j.jacc.2019.05.034. Epub 2019 Jul 23. No abstract available.

PMID:
31350040
4.

Pharmacists and Cardiologists in the ACC.

Kovacs RJ, Birtcher KK, Tisdale JE.

J Am Coll Cardiol. 2019 Jul 23;74(3):470-472. doi: 10.1016/j.jacc.2019.06.015. No abstract available.

PMID:
31319921
5.

Solution Sets to Generate Actionable Knowledge for Cardiovascular Care.

Maddox TM, Gluckman TJ, Doherty J, Kovacs RJ.

J Am Coll Cardiol. 2019 Jul 2;73(25):3349-3351. doi: 10.1016/j.jacc.2019.05.018. No abstract available.

PMID:
31248557
6.

ACC.19, Primary Prevention, and Elizabeth Kovacs (1918 to 2018).

Kovacs RJ.

J Am Coll Cardiol. 2019 Jun 4;73(21):2773-2774. doi: 10.1016/j.jacc.2019.04.013. No abstract available.

PMID:
31146822
7.

Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ.

J Cardiovasc Electrophysiol. 2019 Jun;30(6):941-949. doi: 10.1111/jce.13942. Epub 2019 Apr 21.

PMID:
31006943
8.

Uncovering the Real Power and Value Behind ACC Membership.

Kovacs RJ.

J Am Coll Cardiol. 2019 Apr 23;73(15):1999-2000. doi: 10.1016/j.jacc.2019.03.460. No abstract available.

PMID:
31000003
9.

Measuring patient trust: Comparing measures from a survey and an economic experiment.

Kovacs RJ, Lagarde M, Cairns J.

Health Econ. 2019 May;28(5):641-652. doi: 10.1002/hec.3870. Epub 2019 Feb 14.

PMID:
30767317
10.

The American College of Cardiology: Strategically Aligning for the Next 5 Years.

Valentine CM, Kovacs RJ, Itchhaporia D.

J Am Coll Cardiol. 2018 Sep 11;72(11):1310-1312. doi: 10.1016/j.jacc.2018.08.001. No abstract available.

11.

Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.

Murayama R, Kimura-Asami M, Togo-Ohno M, Yamasaki-Kato Y, Naruse TK, Yamamoto T, Hayashi T, Ai T, Spoonamore KG, Kovacs RJ, Vatta M, Iizuka M, Saito M, Wani S, Hiraoka Y, Kimura A, Kuroyanagi H.

Sci Rep. 2018 Jun 12;8(1):8970. doi: 10.1038/s41598-018-26624-w.

12.

Ondansetron blocks wild-type and p.F503L variant small-conductance Ca2+-activated K+ channels.

Ko JS, Guo S, Hassel J, Celestino-Soper P, Lynnes TC, Tisdale JE, Zheng JJ, Taylor SE, Foroud T, Murray MD, Kovacs RJ, Li X, Lin SF, Chen Z, Vatta M, Chen PS, Rubart M.

Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H375-H388. doi: 10.1152/ajpheart.00479.2017. Epub 2018 Apr 20.

13.

Sudden Cardiac Death in Athletes.

Emery MS, Kovacs RJ.

JACC Heart Fail. 2018 Jan;6(1):30-40. doi: 10.1016/j.jchf.2017.07.014. Review.

14.

Simultaneous recordings of intrinsic cardiac nerve activity and skin sympathetic nerve activity from human patients during the postoperative period.

Shen MJ, Coffey AC, Straka S, Adams DE, Wagner DB, Kovacs RJ, Clark M, Shen C, Chen LS, Everett TH 4th, Lin SF, Chen PS.

Heart Rhythm. 2017 Nov;14(11):1587-1593. doi: 10.1016/j.hrthm.2017.06.030. Epub 2017 Jun 23.

15.

The macro-level drivers of intimate partner violence: New evidence from a multilevel dataset.

Kovacs RJ.

Glob Public Health. 2018 Jul;13(7):944-956. doi: 10.1080/17441692.2017.1317010. Epub 2017 May 4.

16.

Influence of Oral Progesterone Administration on Drug-Induced QT Interval Lengthening: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Flockhart DA, Kovacs RJ.

JACC Clin Electrophysiol. 2016 Dec;2(7):765-774. doi: 10.1016/j.jacep.2016.02.015.

17.

The Academic Medical System: Reinvention to Survive the Revolution in Health Care.

Konstam MA, Hill JA, Kovacs RJ, Harrington RA, Arrighi JA, Khera A; Academic Cardiology Section Leadership Council of the American College of Cardiology.

J Am Coll Cardiol. 2017 Mar 14;69(10):1305-1312. doi: 10.1016/j.jacc.2016.12.024. Review.

18.

Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study.

Ziegler I, Borbély-Jakab J, Sugó L, Kovács RJ.

PDA J Pharm Sci Technol. 2017 May-Jun;71(3):234-244. doi: 10.5731/pdajpst.2016.007096. Epub 2017 Jan 15.

PMID:
28089966
19.

Preparticipation cardiovascular screening: clinical partnership is the only certainty.

Baggish AL, Kovacs RJ.

Br J Sports Med. 2017 Feb;51(3):150-151. doi: 10.1136/bjsports-2016-096954. Epub 2016 Nov 3. No abstract available.

PMID:
27811139
20.

Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram.

Doytchinova A, Hassel JL, Yuan Y, Lin H, Yin D, Adams D, Straka S, Wright K, Smith K, Wagner D, Shen C, Salanova V, Meshberger C, Chen LS, Kincaid JC, Coffey AC, Wu G, Li Y, Kovacs RJ, Everett TH 4th, Victor R, Cha YM, Lin SF, Chen PS.

Heart Rhythm. 2017 Jan;14(1):25-33. doi: 10.1016/j.hrthm.2016.09.019. Epub 2016 Sep 23.

21.

Effect of Body Mass Index on Left Ventricular Mass in Career Male Firefighters.

Korre M, Porto LG, Farioli A, Yang J, Christiani DC, Christophi CA, Lombardi DA, Kovacs RJ, Mastouri R, Abbasi S, Steigner M, Moffatt S, Smith D, Kales SN.

Am J Cardiol. 2016 Dec 1;118(11):1769-1773. doi: 10.1016/j.amjcard.2016.08.058. Epub 2016 Aug 31.

22.

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.

Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA.

Clin Pharmacol. 2016 Jun 3;8:45-50. doi: 10.2147/CPAA.S98790. eCollection 2016.

23.

The ASCVD Risk Estimator App: From Concept to the Current State.

Gluckman TJ, Kovacs RJ, Stone NJ, Damalas D, Mullen JB, Oetgen WJ.

J Am Coll Cardiol. 2016 Jan 26;67(3):350-2. doi: 10.1016/j.jacc.2015.10.068. No abstract available.

24.

Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH THORACIC AORTIC DISEASE REPRESENTATIVE MEMBERS*, Hiratzka LF, Creager MA, Isselbacher EM, Svensson LG; 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Representative Members*, Nishimura RA, Bonow RO, Guyton RA, Sundt TM 3rd; ACC/AHA TASK FORCE MEMBERS, Halperin JL, Levine GN, Anderson JL, Albert NM, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Wijeysundera DN.

Circulation. 2016 Feb 16;133(7):680-6. doi: 10.1161/CIR.0000000000000331. Epub 2015 Dec 4.

PMID:
26637530
25.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.

Estes NA 3rd, Kovacs RJ, Baggish AL, Myerburg RJ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e330-3. doi: 10.1161/CIR.0000000000000247. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621651
26.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.

Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NA 3rd; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e315-25. doi: 10.1161/CIR.0000000000000245. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621650
27.

Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.

Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e310-4. doi: 10.1161/CIR.0000000000000244. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621649
28.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.

Braverman AC, Harris KM, Kovacs RJ, Maron BJ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e303-9. doi: 10.1161/CIR.0000000000000243. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621648
29.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.

Van Hare GF, Ackerman MJ, Evangelista JA, Kovacs RJ, Myerburg RJ, Shafer KM, Warnes CA, Washington RL; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e281-91. doi: 10.1161/CIR.0000000000000240. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621645
30.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.

Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron MS, Mitchell JH; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e262-6. doi: 10.1161/CIR.0000000000000237. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621643
31.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.

Maron BJ, Zipes DP, Kovacs RJ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e256-61. doi: 10.1161/CIR.0000000000000236. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621642
32.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.

Zipes DP, Link MS, Ackerman MJ, Kovacs RJ, Myerburg RJ, Estes NAM 3rd.

J Am Coll Cardiol. 2015 Dec 1;66(21):2412-2423. doi: 10.1016/j.jacc.2015.09.041. Epub 2015 Nov 2. No abstract available.

33.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.

Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ.

J Am Coll Cardiol. 2015 Dec 1;66(21):2406-2411. doi: 10.1016/j.jacc.2015.09.040. Epub 2015 Nov 2. No abstract available.

34.
35.
36.
37.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.

Van Hare GF, Ackerman MJ, Evangelista JK, Kovacs RJ, Myerburg RJ, Shafer KM, Warnes CA, Washington RL.

J Am Coll Cardiol. 2015 Dec 1;66(21):2372-2384. doi: 10.1016/j.jacc.2015.09.036. Epub 2015 Nov 2. No abstract available.

38.
39.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.

Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron MS, Mitchell JH.

J Am Coll Cardiol. 2015 Dec 1;66(21):2350-2355. doi: 10.1016/j.jacc.2015.09.033. Epub 2015 Nov 2. No abstract available.

40.
41.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.

Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e326-9. doi: 10.1161/CIR.0000000000000246. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26527716
42.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.

Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e267-72. doi: 10.1161/CIR.0000000000000238. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26527714
43.

2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Endorsed by the Latin American Society of Interventional Cardiology; PCI WRITING COMMITTEE, Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH; STEMI WRITING COMMITTEE, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE Jr, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Kristin Newby L, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Joseph Woo Y, Zhao DX; ACC/AHA TASK FORCE MEMBERS, Halperin JL, Levine GN, Anderson JL, Albert NM, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Kovacs RJ, Magnus Ohman E, Pressler SJ, Sellke FW, Shen WK, Wijeysundera DN.

Catheter Cardiovasc Interv. 2016 May;87(6):1001-19. doi: 10.1002/ccd.26325. No abstract available.

PMID:
26489034
44.

Using Practice-Based Evidence to Reduce Disparities in Care: A Virtuous Cycle Turns.

Kovacs RJ.

J Am Coll Cardiol. 2015 Sep 15;66(11):1234-1235. doi: 10.1016/j.jacc.2015.07.046. No abstract available.

45.

The changing face of team care, and a challenge for the future.

Kovacs RJ, Drozda JP Jr.

J Am Coll Cardiol. 2015 May 19;65(19):2137-9. doi: 10.1016/j.jacc.2015.03.556. No abstract available.

46.

Practical management of anticoagulation in patients with atrial fibrillation.

Kovacs RJ, Flaker GC, Saxonhouse SJ, Doherty JU, Birtcher KK, Cuker A, Davidson BL, Giugliano RP, Granger CB, Jaffer AK, Mehta BH, Nutescu E, Williams KA.

J Am Coll Cardiol. 2015 Apr 7;65(13):1340-1360. doi: 10.1016/j.jacc.2015.01.049. Review.

47.

2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK; American College of Cardiology/Americal Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons.

J Thorac Cardiovasc Surg. 2015 Mar;149(3):e5-23. doi: 10.1016/j.jtcvs.2014.11.002. Epub 2014 Nov 7. Review. No abstract available.

48.

Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.

Tisdale JE, Allen MR, Overholser BR, Jaynes HA, Kovacs RJ.

J Cardiovasc Electrophysiol. 2015 Jun;26(6):671-7. doi: 10.1111/jce.12641. Epub 2015 Mar 31.

49.

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study.

Kovacs RJ, Maldonado G, Azaro A, Fernández MS, Romero FL, Sepulveda-Sánchez JM, Corretti M, Carducci M, Dolan M, Gueorguieva I, Cleverly AL, Pillay NS, Baselga J, Lahn MM.

Cardiovasc Toxicol. 2015 Oct;15(4):309-23. doi: 10.1007/s12012-014-9297-4.

50.

Protecting the heart of the American athlete: proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC.

Lawless CE, Asplund C, Asif IM, Courson R, Emery MS, Fuisz A, Kovacs RJ, Lawrence SM, Levine BD, Link MS, Martinez MW, Matherne GP, Olshansky B, Roberts WO, Salberg L, Vetter VL, Vogel RA, Whitehead J.

J Am Coll Cardiol. 2014 Nov 18-25;64(20):2146-71. doi: 10.1016/j.jacc.2014.08.027. Epub 2014 Oct 8. No abstract available.

Supplemental Content

Loading ...
Support Center